EDSA - CIK 0001540159
The table below shows Edesa Biotech, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.80M | $1.00M | $5.40M | $7.09M | $7.84M | $7.21M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $11.51M |
| $1.68M |
| $6.44M |
| $9.09M |
| $12.09M |
| $8.10M |
| Property, plant & equipment | - | $0.00 | $8.70K | $12.69K | $14.99K | $14.81K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $13.53M | $3.81M | $8.89M | $11.58M | $14.58M | $10.76M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $1.08M | $1.83M | $1.82M | $2.14M | $1.46M | $1.53M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | $1.83M | $1.84M | $2.18M | $1.53M | $1.65M |
| Retained earnings | -$65.91M | -$58.59M | -$52.42M | -$44.04M | -$26.50M | -$13.13M |
| Total equity | $12.45M | $1.98M | $7.05M | $9.39M | $13.06M | $6.63M |